In the News

Propeller Health’s new deal with Orion Corporation extends its European reach

Wisconsin-based Propeller Health is partnering with Finnish pharmaceuticals and diagnostics company Orion Corporation to help European asthma and COPD sufferers. Starting in 2019, the companies will begin developing a custom-built Propeller sensor for Orion’s Easyhaler line of inhaled pulmonary drugs. These sensors will connect to Propeller’s...

Netsmart and American Well Partner to Address the Opioid Crisis at HIMSS19

Netsmart, a provider of electronic health records (EHR), solutions, and services to behavioral health, social services, and post-acute organizations, is partnering with American Well to provide a new approach to addressing the nation’s growing opioid crisis. The partnership was revealed as part of the Interoperability...

Company that helps speed drug approvals raises $27 million

Manhattan-based health technology company Aetion has added $27 million to its previously announced Series B round, bringing the total raised in the round to $63 million and the company’s total funding to $77 million. The company attracted strategic investment from Sanofi, UCB, McKesson Ventures, and...

Global Health Leaders Back Aetion with $27 Million Strategic Investment

Aetion, a healthcare technology company that delivers the real-world analytics and evidence platform needed to engage in value-based care, announced that it has attracted strategic investment from global leaders in biopharma and healthcare services, including McKesson Ventures; Sanofi; UCB; and Horizon Health Services, Inc., a...

M&A Analysis: 10 Reasons Why ResMed Acquired Propeller Health for $225M

On December 3, ResMed announced that it was acquiring digital therapeutics manufacturer Propeller Health for $225 million. Part of ResMed’s goal in making this acquisition is to help establish itself as a leader in COPD management across all stages of the disease. ResMed is not...